News
The FDA granted priority review to the application and will decide whether to approve the treatment by Dec. 5.
Pfizer raised its full-year profit forecast on Tuesday while reporting second-quarter results that topped Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback